Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...
Chimeric antigen receptor (CAR) -T-cell therapies have yielded remarkable results in the treatment of hematological malignancies. Several autologous CAR T-cell products have received marketing ...
Researchers from the Critical Analytics for Manufacturing Personalized Medicine (CAMP), an interdisciplinary research group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), in ...
A roundtable discussion reveals how hybrid distributed models could provide a bridge from centralized cell-therapy ...
CDMO and multimodal biosafety testing organization, today announced the enhancement of its dedicated GMP cell banking suites ...
Cell and gene therapy medicinal products are part of innovative therapies that involve the use of living cells, modified genes, or viral vectors to treat serious or chronic diseases. The quality and ...
Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...
TALON PV is poised to anchor the U.S. solar supply chain by establishing an independent, 9.6 GW domestic cell manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results